Rivera F, Izquierdo-Manuel M, Garcia-Alfonso P, Martinez de Castro E, et al. Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial. Eur J Cancer 2021;145:158-167.
PMID: 33485079